{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:23:05Z","timestamp":1791307385051,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100022840","name":"Serum Institute of India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.dsx.2024.103102","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T22:46:01Z","timestamp":1723502761000},"page":"103102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Significance of Bacillus Calmette-Guerin (BCG) vaccine intervention for patients with Type 1 Diabetes (T1D): A systematic review and meta-analysis"],"prefix":"10.1016","volume":"18","author":[{"given":"Sunil B.","family":"Korde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita R.","family":"Pillewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket R.","family":"Dumbre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali R.","family":"Bandgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajakta S.","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-4896","authenticated-orcid":false,"given":"Vandana S.","family":"Nikam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.dsx.2024.103102_bib1","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.1073\/pnas.0803429105","article-title":"Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism","volume":"105","author":"Ban","year":"2008","journal-title":"ProcNatlAcadSci U S A"},{"issue":"3","key":"10.1016\/j.dsx.2024.103102_bib2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1073\/pnas.87.3.968","article-title":"Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1","volume":"87","author":"Jacob","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.dsx.2024.103102_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-\u03b1 signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"10.1016\/j.dsx.2024.103102_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.1998.1413","article-title":"Multidose streptozotocin induction of diabetes in BALB\/cBy mice induces a T cell proliferation defect in thymocytes which is reversible by interleukin-4","volume":"192","author":"Wood","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1016\/j.dsx.2024.103102_bib5","first-page":"115","article-title":"Role of immunomodulation of BCG therapy on AML remission","volume":"14","author":"Kennedy","year":"2021","journal-title":"Int Med Case Rep J"},{"issue":"3","key":"10.1016\/j.dsx.2024.103102_bib6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/vaccines10030390","article-title":"Protective efficacy of BCG vaccine against Mycobacterium leprae and non-tuberculous mycobacterial infections","volume":"10","author":"Orujyan","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.dsx.2024.103102_bib7","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: implication for vaccine design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103102_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1189\/jlb.5RI0315-096R","article-title":"Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines","volume":"98","author":"Blok","year":"2015","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103102_bib9","article-title":"Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study","volume":"1","author":"Moorlag","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.dsx.2024.103102_bib10","doi-asserted-by":"crossref","unstructured":"Singh AK, Netea MG, Bishai WR. BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases. J Clin Invest. 131(11):e148291.","DOI":"10.1172\/JCI148291"},{"key":"10.1016\/j.dsx.2024.103102_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycaemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations","volume":"3","author":"K\u00fchtreiber","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.dsx.2024.103102_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8954125","article-title":"Therapeutic effects of BCG vaccination on type 1 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"2020","author":"Chang","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.dsx.2024.103102_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2018.00029","article-title":"Adjuvant effect of bacille calmette\u2013gu\u00e9rin on hepatitis B vaccine immunogenicity in the preterm and term newborn","volume":"9","author":"Scheid","year":"2018","journal-title":"Front Immunol"},{"issue":"8899","key":"10.1016\/j.dsx.2024.103102_bib14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(94)91583-0","article-title":"Effect of adjuvant therapy on development of diabetes in mouse and man","volume":"343","author":"Shehadeh","year":"1994","journal-title":"Lancet Lond Engl"},{"issue":"9064","key":"10.1016\/j.dsx.2024.103102_bib15","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0140-6736(05)62100-9","article-title":"BCG vaccine in insulin-dependent diabetes mellitus. IMDIAB Group","volume":"349","author":"Pozzilli","year":"1997","journal-title":"Lancet Lond Engl."},{"issue":"10","key":"10.1016\/j.dsx.2024.103102_bib16","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2337\/diacare.21.10.1691","article-title":"Effect of bacille Calmette-Gu\u00e9rin vaccination on C-peptide secretion in children newly diagnosed with IDDM","volume":"21","author":"Elliott","year":"1998","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.dsx.2024.103102_bib17","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2337\/diacare.22.10.1703","article-title":"Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study","volume":"22","author":"Allen","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2024.103102_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1749-6632.2002.tb02990.x","article-title":"BCG vaccination and GAD65 and IA-2 autoantibodies in autoimmune diabetes in southern India","volume":"958","author":"Sanjeevi","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.dsx.2024.103102_bib19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/diacare.28.5.1204","article-title":"Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes","volume":"28","author":"Huppmann","year":"2005","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.dsx.2024.103102_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.dsx.2024.103102_bib21","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (Heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Inf Disp"},{"key":"10.1016\/j.dsx.2024.103102_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S002217240006945X","article-title":"BCG vaccination of children against leprosy in Uganda: final results","volume":"87","author":"Stanley","year":"1981","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.dsx.2024.103102_bib23","first-page":"1251","volume":"vol. 23","author":"Stensballe","year":"2005"},{"issue":"7","key":"10.1016\/j.dsx.2024.103102_bib24","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.53.7.1588","article-title":"Use of bacille calmette-gu\u00e8rin (BCG) in multiple sclerosis","volume":"53","author":"Ristori","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.dsx.2024.103102_bib25","doi-asserted-by":"crossref","first-page":"101696","DOI":"10.1016\/j.canep.2020.101696","article-title":"Association between Bacillus Calmette-Guerin (BCG) vaccination and lymphoma risk: A systematic review and meta-analysis","volume":"65","author":"Salmon","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.dsx.2024.103102_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2023.100198","article-title":"Engineering live attenuated vaccines. Old dogs learning new tricks","volume":"6","author":"Plocica","year":"2023","journal-title":"J Transl Autoimmun"},{"issue":"11","key":"10.1016\/j.dsx.2024.103102_bib27","article-title":"BCG turns 100: its nontraditional uses against viruses. cancer, and immunologic diseases","volume":"131","author":"Singh Alok","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.dsx.2024.103102_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0008-8749(91)90138-2","article-title":"Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse. I. Generation of suppressor macrophages in spleen cells of BCG-vaccinated mice","volume":"138","author":"Yagi","year":"1991","journal-title":"Cell Immunol"},{"key":"10.1016\/j.dsx.2024.103102_bib29","article-title":"BacilleCalmette Guerin (BCG) and prevention of types 1 and 2 diabetes: results of two observational studies","volume":"181","author":"Dias","year":"2023","journal-title":"PLoS One"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T12:29:11Z","timestamp":1731328151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402124001632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1871402124001632"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103102","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of Bacillus Calmette-Guerin (BCG) vaccine intervention for patients with Type 1 Diabetes (T1D): A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103102"}}